the psychoactive ingredient in hallucinogenic (or ‘magic’) mushrooms, can also be given to those with treatment resistant depression (TRD). The two drugs have now been placed on the list of ...
The popularity of psilocybin is fast-rising, with an estimated 8 million American adults using it in 2023. The percentage of US adults who have used psilocybin at least once in their lifetime, ...
Ketamine, a hallucinogenic drug approved as an anesthetic, has been used to treat adults with depression, PTSD and other conditions, and studied in youth with depression.
In the first study, a team of experts at NYU Langone Health found that psilocybin accompanied by psychotherapy significantly reduced anxiety, depression, obsessive thoughts, anger toward others ...